These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 1410893

  • 1. [Intravenous immunoglobulins and anti-idiotypic suppression of auto-immunity].
    Jobin D, Kazatchkine M.
    Rev Med Interne; 1992; 13(2):162-5. PubMed ID: 1410893
    [Abstract] [Full Text] [Related]

  • 2. [Anti-idiotype suppression of autoimmunity by therapeutic intravenous immunoglobulins].
    Rossi F, Dietrich G, Kazatchkine M.
    Ann Med Interne (Paris); 1988; 139(5):359-68. PubMed ID: 3144223
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Anti-idiotypes against autoantibodies in normal immunoglobulins: evidence for network regulation of human autoimmune responses.
    Rossi F, Dietrich G, Kazatchkine MD.
    Immunol Rev; 1989 Aug; 110():135-49. PubMed ID: 2676846
    [Abstract] [Full Text] [Related]

  • 5. Idiotypic modulation of autoimmunity by therapeutic human immunoglobulin preparations (IVIg).
    Kaveri SV, Dietrich G, Jobin D, Rossi F, Sultan Y, Lockwood CM, Kazatchkine MD.
    Adv Nephrol Necker Hosp; 1992 Aug; 21():329-46. PubMed ID: 1566650
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Idiotype-specific intravenous immunoglobulin (IVIG) for therapy of autoimmune diseases.
    Blank M, Bashi T, Shoenfeld Y.
    Methods Mol Biol; 2014 Aug; 1060():353-61. PubMed ID: 24037850
    [Abstract] [Full Text] [Related]

  • 8. Intravenous immunoglobulin (IVIg) in the treatment of autoimmune and inflammatory diseases.
    Ruiz de Souza V, Kaveri SV, Kazatchkine MD.
    Clin Exp Rheumatol; 1993 Aug; 11 Suppl 9():S33-6. PubMed ID: 8354005
    [Abstract] [Full Text] [Related]

  • 9. Novel cross-reactive anti-idiotype antibodies with properties close to the human intravenous immunoglobulin (IVIg).
    Macias A, Arce S, Leon J, Mustelier G, Bombino G, Domarco A, Perez R, Lage A.
    Hybridoma; 1999 Jun; 18(3):263-72. PubMed ID: 10475241
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Anti-idiotypic immunity in autoimmunity.
    Bigazzi PE.
    Ann N Y Acad Sci; 1986 Jun; 475():66-80. PubMed ID: 3538975
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Normal polyspecific immunoglobulin G (IVIg) in the treatment of autoimmune diseases.
    Hurez V, Kaveri SV, Kazatchkine MD.
    J Autoimmun; 1993 Dec; 6(6):675-81. PubMed ID: 8155249
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.